Such degradation is crucial for modulating HIF1 activity under varying cellular conditions, thereby maintaining tight control over hypoxia-inducible transcription factors that influence gene expression related to angiogenesis, metabolism, and tumor progression, potentially increasing tumor susceptibility to immune-mediated destruction and improving responsiveness to traditional therapies. The gene discussed is HIF1A; the disease is neoplasm.